We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $8.34B
1-Year Est. Return 46.58%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+46.58%
3 Year Est. Return
+191.6%
5 Year Est. Return
+200.35%
10 Year Est. Return
+3,561.44%
AUM
$7.98B
AUM Growth
-$21.8M
Cap. Flow
-$149M
Cap. Flow %
-1.86%
Top 10 Hldgs %
34.31%
Holding
287
New
30
Increased
70
Reduced
150
Closed
36

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$82.6M
2
EMBJ
Embraer S.A. ADS
EMBJ
+$56.2M
3
TBBB icon
BBB Foods
TBBB
+$39.9M
4
NTRA icon
Natera
NTRA
+$35.9M
5
LOAR icon
Loar Holdings
LOAR
+$29.9M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$171M
2
NVDA icon
NVIDIA
NVDA
+$107M
3
INTC icon
Intel
INTC
+$54.3M
4
DNLI icon
Denali Therapeutics
DNLI
+$24.1M
5
NFLX icon
Netflix
NFLX
+$20.2M

Sector Composition

Rank Sector Weight
1 Technology 31.65%
2 Consumer Discretionary 19.21%
3 Healthcare 16.85%
4 Communication Services 13.51%
5 Industrials 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APP icon
226
Applovin
APP
$141B
$553K 0.01%
6,645
+1,582
+31% +$123K
ONT
227
Onterris Inc
ONT
$826M
$549K 0.01%
+12,331
New +$555K
DKNG icon
228
DraftKings
DKNG
$11.7B
$546K 0.01%
14,294
+1,462
+11% +$60.7K
SDRL icon
229
Seadrill
SDRL
$2.66B
$545K 0.01%
10,585
-107,644
-91% -$5.45M
RELY icon
230
Remitly
RELY
$5.05B
$528K 0.01%
43,581
-223
-0.5% -$3.46K
CRBP icon
231
Corbus Pharmaceuticals
CRBP
$165M
$513K 0.01%
+11,328
New +$476K
NEWP
232
New Pacific Metals
NEWP
$885M
$492K 0.01%
327,957
-392,566
-54% -$746K
JANX icon
233
Janux Therapeutics
JANX
$973M
$484K 0.01%
11,554
-37
-0.3% -$1.74K
TXG icon
234
10x Genomics
TXG
$5.97B
$474K 0.01%
24,394
-479,780
-95% -$12.6M
NAMS icon
235
NewAmsterdam Pharma
NAMS
$3.21B
$468K 0.01%
24,385
-81
-0.3% -$1.63K
CMPS
236
Compass Pathways
CMPS
$1.59B
$462K 0.01%
76,556
+761
+1% +$5.99K
BCYC
237
Bicycle Therapeutics
BCYC
$270M
$438K 0.01%
21,658
+390
+2% +$8.81K
UCTT
238
Ultra Clean Holdings
UCTT
$4B
$423K 0.01%
+8,627
New +$387K
VSXY
239
Victoria's Secret
VSXY
$7.08B
$421K 0.01%
+23,845
New +$454K
KRUS icon
240
Kura Sushi USA
KRUS
$580M
$322K ﹤0.01%
+5,111
New +$516K
ETSY icon
241
Etsy
ETSY
$7.89B
$292K ﹤0.01%
4,946
-6
-0.1% -$384
L icon
242
Loews
L
$23.7B
$281K ﹤0.01%
3,759
+51
+1% +$3.86K
KTOS icon
243
Kratos Defense & Security Solutions
KTOS
$9.73B
$255K ﹤0.01%
+12,755
New +$249K
EWCZ
244
DELISTED
European Wax Center
EWCZ
$243K ﹤0.01%
24,446
+202
+0.8% +$2.29K
GDX icon
245
VanEck Gold Miners ETF
GDX
$23.8B
$208K ﹤0.01%
6,122
-259,636
-98% -$8.9M
AIRS icon
246
AirSculpt Technologies
AIRS
$344M
$204K ﹤0.01%
51,009
-187,227
-79% -$897K
RSKD icon
247
Riskified
RSKD
$698M
$165K ﹤0.01%
+25,757
New +$146K
VZLA
248
Vizsla Silver
VZLA
$1.14B
$98.3K ﹤0.01%
54,925
-133,398
-71% -$209K
SHIM icon
249
Shimmick
SHIM
$168M
$55.9K ﹤0.01%
36,041
-59,010
-62% -$158K
VLN icon
250
Valens Semiconductor
VLN
$176M
$43.8K ﹤0.01%
13,724
– –
8 9
10
11 12

Similar funds

AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return

Gilder Gagnon Howe & Co's Q2 2024 Portfolio in Review

As of Q2 2024, Gilder Gagnon Howe & Co held 287 positions worth $7.98B, down 0.27% from $8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Gilder Gagnon Howe & Co's Q2 2024 filing shows 30 new, 70 increased, 150 reduced and 36 closed positions. Its largest new stake was Boston Scientific: 1,128,740 shares worth $86.9M. The largest sale was Shockwave Medical, Inc. Common Stock, an estimated $171M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Gilder Gagnon Howe & Co's largest Q2 2024 buy was Boston Scientific: 1,128,740 shares worth $86.9M.
  • Gilder Gagnon Howe & Co added most to BBB Foods in Q2 2024, an estimated $39.9M increase.
  • Gilder Gagnon Howe & Co's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $107M.
  • Gilder Gagnon Howe & Co fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $171M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 34% of its $7.98B portfolio in Q2 2024.
  • Gilder Gagnon Howe & Co opened 30 new positions and closed 36 in Q2 2024.
  • Gilder Gagnon Howe & Co's portfolio value fell 0.27% quarter-over-quarter to $7.98B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2024, filed 14 Aug 2024.